Arcutis Biotherapeutics (ARQT) Earnings Date & Reports

A.I. Advisor

published Earnings

ARQT is expected to report earnings to rise 9.81% to -46 cents per share on November 06

Arcutis Biotherapeutics ARQT Stock Earnings Reports

Q3'24

Est.

$-0.46

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.37

Q4'23

Beat

by $0.06

Q3'23

Beat

by $0.18

The last earnings report on August 14 showed earnings per share of -41 cents, beating the estimate of -50 cents. With 1.65M shares outstanding, the current market capitalization sits at 1.09B.

View a ticker or compare two or three

Compare

ARQT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ARQT
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ARQT (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company, which engages in the development and commercialization of treatments for dermatological diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3027 Townsgate Road

Phone

+1 805 418-5006

Employees

296

Web

https://www.arcutis.com